about
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidenceMefloquine for preventing malaria in pregnant womenMefloquine safety and tolerability in pregnancy: a systematic literature reviewResuscitating the Dying AutopsyBarriers and facilitators to health care seeking behaviours in pregnancy in rural communities of southern Mozambique.Community perceptions of pre-eclampsia and eclampsia in southern Mozambique.The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan AfricaCost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern MozambiqueIntermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trialEconomic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancyMortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort StudyHeterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regionsCommunity health worker knowledge and management of pre-eclampsia in southern MozambiqueThe effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataAn autopsy study of maternal mortality in Mozambique: the contribution of infectious diseasesA randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic.Clinico-pathological discrepancies in the diagnosis of causes of maternal death in sub-Saharan Africa: retrospective analysisDihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.Malaria prevention with IPTp during pregnancy reduces neonatal mortalityFirst-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studiesIn-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination StrategiesEffects of HIV infection on maternal and neonatal health in southern Mozambique: A prospective cohort study after a decade of antiretroviral drugs roll out.Validity of a minimally invasive autopsy tool for cause of death determination in pediatric deaths in Mozambique: An observational study.Validity of a minimally invasive autopsy for cause of death determination in stillborn babies and neonates in Mozambique: An observational study.Burden and impact of Plasmodium vivax in pregnancy: A multi-centre prospective observational study.Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique.Association of severe malaria outcomes with platelet-mediated clumping and adhesion to a novel host receptor.Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensitiesErythropoietin levels are not independently associated with malaria-attributable severe disease in Mozambican childrenAntimicrobial drug resistance trends of bacteremia isolates in a rural hospital in southern MozambiqueA targeted association study of immunity genes and networks suggests novel associations with placental malaria infection.Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women from a rural area of southern Mozambique.Malaria-related anaemia.Costs associated with low birth weight in a rural area of Southern Mozambique.Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.Malaria and HIV infection in Mozambican pregnant women are associated with reduced transfer of antimalarial antibodies to their newborns.Persistence of Plasmodium falciparum parasites in infected pregnant Mozambican women after delivery.Challenges in the diagnosis of iron deficiency in children exposed to high prevalence of infections.Rosetting in Plasmodium vivax: a cytoadhesion phenotype associated with anaemiaParity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy.
P50
Q21032450-2AC851D6-90B5-48DD-88A9-ADD2BC0C92A1Q24186956-590ED746-5278-47CD-9849-23823BB3962BQ24599164-A2653BA0-D53A-4694-ACDD-15713EC00EABQ26772243-58B9D9DB-5D9C-4D3C-8633-34E0236C16BEQ27302900-71FB6962-658A-44F9-8F78-FA60B86F4F8CQ27302968-801D58BB-21A2-422E-91D1-D69AE02D8F30Q28474404-9BABE910-293D-4D78-90DD-7049EE5FD2ACQ28475795-7F6013FE-F520-4DDF-919B-B8E852EBB06AQ28543146-9B89E29D-8C6F-4139-9984-3B6721177293Q28546725-C69D73ED-CC57-4C80-81BC-A2A97F8EF867Q28550346-E131544F-2975-471D-A51E-3BD78A3B1480Q28559557-6261FCAE-047E-48B1-BE29-17E4C9577A0AQ30820061-73F6293C-CDCB-4D14-B2BB-DBB74F2BD25EQ30936416-5C9E4463-F9A6-4E70-8FFC-076A377B65AAQ33320675-96BF75B4-A711-4487-B07E-A07BAF883319Q33327356-AF84379C-BF2A-4F3A-8F1B-0C6A793AAF0DQ33412504-E598E6FB-B3F8-4633-915D-3E4690BD50B8Q33516563-2431B4DF-EA76-4E5A-9EB2-3E4A2EF950D2Q33535850-4C5552C1-9A71-43E8-8FDB-84B272A46AA9Q33626397-66AA1175-2FDF-4A83-B94E-68C380CE3FBDQ33683683-50D1975A-9373-45C0-87D6-A297101C1614Q33757461-DF333BF8-186E-4BCD-9519-2BE8F0409F5EQ33817234-6215F6A2-9D36-45D8-9314-07327DA7190CQ33817443-6E684D4B-0B97-4ED7-B241-4C8360A24984Q33825631-CE785C79-8EF5-4ADA-AEAD-D1015BF2DD6FQ33840983-237EA95E-3E1A-447E-A2F8-3D7347E1AFBFQ33894907-CEA2672B-FB24-4061-9C4E-8227A9A90EF5Q33910163-7B5557B7-EF16-49A4-8428-4303B71D9EBDQ34017654-2CD7E071-4A67-46F5-88AA-671DE98B7EFBQ34030297-7BB90733-D0FE-47ED-820D-3CCC16EBC798Q34031788-982AFEDC-00BE-4BD7-8144-EE18EDB9B1EFQ34035360-82117D12-B6B5-48B6-ADD3-A7274345D87FQ34076799-CBED16C7-3B95-468E-8958-821E8D6705DBQ34103336-3DA02E84-4CA8-4271-BB42-583BB6AE927EQ34359432-37DFAA5C-88A3-41EF-BBBA-9CAC92FEE76EQ34441166-7085E166-5AE2-4526-918E-DA97F4075430Q34484783-CE34D983-A75D-47FB-BBBD-F041EB3ADC16Q34500512-56F18D08-738B-4B29-A365-D0D27359D474Q34675111-EC6DD94F-3BE7-4612-B91D-0D980DD89318Q34740303-D152A29E-7462-43E2-B05A-FBBB67909D4F
P50
description
researcher ORCID ID = 0000-0002-2641-6907
@en
wetenschapper
@nl
name
Clara Menéndez
@ast
Clara Menéndez
@en
Clara Menéndez
@es
Clara Menéndez
@nl
type
label
Clara Menéndez
@ast
Clara Menéndez
@en
Clara Menéndez
@es
Clara Menéndez
@nl
altLabel
Clara Menendez
@en
prefLabel
Clara Menéndez
@ast
Clara Menéndez
@en
Clara Menéndez
@es
Clara Menéndez
@nl
P214
P1053
Q-3446-2016
P106
P1153
55942254700
P1580
P21
P214
P31
P496
0000-0002-2641-6907
P734
P735
P7859
viaf-305881142